Skip to main content

Cancer Cohort Consortium Approach: Cancer Epidemiology in Immunosuppressed Groups

  • Protocol
Cancer Epidemiology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 471))

Summary

Nearly 40 years have passed since the publication of the first report showing higher cancer risks in recipients of organ transplants. Thereafter, studies carried out in immunosuppressed persons have greatly expanded our knowledge on the spectrum of cancers associated with infections. Clinical investigations following the expanding practice of organ transplantation, and since the 1980s, studies on human immunodeficiency virus (HIV)-infected persons have thereafter confirmed and extended these early observations. The comparison of the spectrum of cancers seen in excess in these two groups of populations offers an original viewpoint into the association of immunosuppression and cancer. Combining longitudinal data from different cohorts of HIV-infected persons and of transplant recipients represents a further tool for better quantifying the spectrum of cancers associated with immunodepression. In this chapter, the use of this methodologic approach in southern Europe is illustrated and limitations are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Doll R, Kinlen L (1970) Immunosurveil-lance and cancer: epidemiological evidence. Br Med J 4, 420–422.

    Article  CAS  PubMed  Google Scholar 

  2. International Collaboration on HIV and Cancer (2000) The impact of highly active anti-retroviral therapy on the incidence of cancer in people infected with the human immunodeficiency virus. Collaborative reanalysis of individual data on 47,936 HIV-infected people from 23 cohort studies in 12 developed countries. J Natl Cancer Inst 92, 1823–1830.

    Article  Google Scholar 

  3. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels AA. (2007) AIDS-related cancers and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99, 962–972.

    Article  PubMed  Google Scholar 

  4. Serraino D, Boschini A, Carrieri MP et al., (2000) Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 14, 553–559.

    Article  CAS  PubMed  Google Scholar 

  5. Grulich AE, van Leuwen MT, O Falster M, M Vajdic C. (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370, 59–67.

    Article  PubMed  Google Scholar 

  6. Serraino D, Piselli P, Angeletti C, et al. (2005) Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. B J Cancer 92, 572–575.

    CAS  Google Scholar 

  7. Pedotti P, Cardillo M, Rossini G, et al. (2003) Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 76, 1448–1451.

    Article  PubMed  Google Scholar 

  8. Herrero JL, Lorenzo M, Quiroga J, et al. (2005) De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 11, 89–97.

    Article  PubMed  Google Scholar 

  9. World Health Organization (1992) International Classification of Diseases and Related Problems, 10th rev. Geneva, Switzerland: World Health Organization.

    Google Scholar 

  10. Parkin DM, Whelan SL, Ferlay J, et al. (eds.) (1997) Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publications No. 143. Lyon, France : IARC Press.

    Google Scholar 

  11. Parkin DM, Whelan SL, Ferlay J, Teppo L, and Thomas DB (eds.) (2002) Cancer Incidence in Five Continents, Vol. VIII, IARC Scientific Publications No. 155. Lyon, France : IARC Press: Lyon.

    Google Scholar 

  12. Breslow NE, Day NE (1987) Statistical Methods in Cancer Research, Vol. 2. The design and analysis of cohort studies. IARC Scientific Publications No. 82. Lyon, France : : IARC Press.

    Google Scholar 

  13. Dal Maso L, Franceschi S, Polesel J, et al. (2003) Risk of cancer in persons with AIDS in Italy, 1985–98. 89, 94–100.

    Google Scholar 

  14. Jones ME, Swerdlow AJ (1998) Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol 148, 1012–1017.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Serraino, D. (2009). Cancer Cohort Consortium Approach: Cancer Epidemiology in Immunosuppressed Groups. In: Verma, M. (eds) Cancer Epidemiology. Methods in Molecular Biology, vol 471. Humana Press. https://doi.org/10.1007/978-1-59745-416-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-416-2_20

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-987-1

  • Online ISBN: 978-1-59745-416-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics